supplementhackr
Major

Tab A Vite Multiple Vitamins + Iron

Serving
1 Tablet(s)
Form
tablet
UPC
309040531605
DSLD
216043
Avoid-flaggedObjective label signals
Flagged excipients
4
1 avoid · 3 caution
FDA recalls
0
no recall history
CAERS reports
2
FDA consumer events
Certifications
0
none recorded
1 avoid-level excipient · Every flag below links to the authority's published citation.

Supplement Facts

11 active ingredients
IngredientAmount% DV
Vitamin A
UNII · 81G40H8B0T
1500 mcg167%
Vitamin C
UNII · PQ6CK8PD0R
50 mg56%
Vitamin D
UNII · 9VU1KI44GP
10 mcg50%
Thiamine
ThiaminUNII · X66NSO3N35
2 mg167%
Riboflavin
UNII · TLM2976OFR
2.5 mg192%
Niacin
UNII · 2679MF687A
20 mg125%
Vitamin B6
UNII · KV2JZ1BI6Z
1 mg59%
Folate
UNII · 935E97BOY8
667 mcg DFE167%
Vitamin B12
UNII · 8406EY2OQA
1 mcg42%
Pantothenic Acid
Pantothenic Acid (Vitamin B5)UNII · 19F5HK2737
1 mg20%
Iron
UNII · E1UOL152H7
15 mg83%
What this product supports · authorized claims

17 authority-backed effects

Rolled up from EFSA / FDA / NIH ODS authorized function claims on this product's active ingredients. Each row shows which ingredients contribute.

Flagged excipients

4 flagged · authority citations

  • ● AVOIDTitanium Dioxide
    color

    Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.

    eur-lex.europa.eu →efsa.europa.eu →ecfr.gov →
  • ◐ CAUTIONFD&C Yellow #5 Lake
    color

    EU requires warning label 'may have an adverse effect on activity and attention in children' per Commission Regulation 1333/2008 Annex III (following Southampton study 2007). FDA requires specific label declaration (21 CFR 74.705).

    eur-lex.europa.eu →ecfr.gov →
  • ◐ CAUTIONFD&C Yellow #6 Lake
    color

    EU requires 'attention in children' warning per Reg 1333/2008 Annex III (Southampton study 2007). Banned in Norway + Finland; allowed in US under 21 CFR 74.706 with declaration.

    eur-lex.europa.eu →
  • ◐ CAUTIONBHT
    preservative

    NTP 15th Report on Carcinogens (2021) classifies BHT/BHA as not listed, but BHA is 'reasonably anticipated to be a human carcinogen'. EU permits BHT with strict limits under Commission Regulation 1333/2008 Annex II.

    ntp.niehs.nih.gov →eur-lex.europa.eu →
FDA CAERS · adverse event context
2
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.

CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →

Other ingredients

Dicalcium Phosphate · Microcrystalline Cellulose · Stearic Acid · Starch · Gelatin · Croscarmellose Sodium · Hypromellose · Magnesium Stearate · Silica · Talc · Sucrose · Polyethylene Glycol · Mineral Oil · Sodium Ascorbate · Triglycerides · Tocopherols